1. Home
  2. TUYA vs ALVO Comparison

TUYA vs ALVO Comparison

Compare TUYA & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tuya Inc. each representing one

TUYA

Tuya Inc. each representing one

HOLD

Current Price

$2.01

Market Cap

1.3B

Sector

Technology

ML Signal

HOLD

Logo Alvotech

ALVO

Alvotech

HOLD

Current Price

$4.17

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TUYA
ALVO
Founded
2014
2013
Country
China
Luxembourg
Employees
N/A
1460
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.1B
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
TUYA
ALVO
Price
$2.01
$4.17
Analyst Decision
Strong Buy
Buy
Analyst Count
1
4
Target Price
$3.49
$8.00
AVG Volume (30 Days)
1.0M
721.1K
Earning Date
05-11-2026
05-06-2026
Dividend Yield
5.40%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$13.76
$13.28
Revenue Next Year
$11.90
$18.63
P/E Ratio
$27.45
$18.20
Revenue Growth
N/A
N/A
52 Week Low
$1.87
$2.94
52 Week High
$2.88
$9.94

Technical Indicators

Market Signals
Indicator
TUYA
ALVO
Relative Strength Index (RSI) 44.29 64.02
Support Level N/A $3.09
Resistance Level $2.48 $5.46
Average True Range (ATR) 0.09 0.28
MACD 0.01 0.11
Stochastic Oscillator 40.85 76.06

Price Performance

Historical Comparison
TUYA
ALVO

About TUYA Tuya Inc. each representing one

Tuya Inc is an AI cloud platform service provider dedicated to bringing AI into everyday life. The group leverages its TuyaOpen open-source framework and universal AI Agent engines, including the AI Agent development platform, to integrate multimodal AI capabilities and reduce barriers to AI development. It drives the adoption of AI-powered lifestyles and speeds up the integration of AI with the physical world. It offers physical AI solutions for smart devices, commercial use, and industry developers using cloud computing and spatial intelligence. It builds a developer community that collaborates to create smart solutions grounded in sustainability, security, efficiency, agility, and openness. All the Group's revenue are derived from within the PRC.

About ALVO Alvotech

Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.

Share on Social Networks: